These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 32767251)

  • 1. The association of anti-PLA2R with clinical manifestations and outcomes in idiopathic membranous nephropathy: a meta-analysis.
    Rao SJ; Shen Q; Wang HM; Tang S; Wang XY
    Int Urol Nephrol; 2020 Nov; 52(11):2123-2133. PubMed ID: 32767251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between renal tissues phospholipase A2 receptor and its serum antibody and clinical condition and prognosis of idiopathic membranous nephropathy: a meta-analysis.
    Dong D; Fan TT; Wang YY; Zhang L; Song L; Zhang L
    BMC Nephrol; 2019 Dec; 20(1):444. PubMed ID: 31791262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.
    Radice A; Pieruzzi F; Trezzi B; Ghiggeri G; Napodano P; D'Amico M; Stellato T; Brugnano R; Ravera F; Rolla D; Pesce G; Giovenzana ME; Londrino F; Cantaluppi V; Pregnolato F; Volpi A; Rombolà G; Moroni G; Ortisi G; Sinico RA
    J Nephrol; 2018 Apr; 31(2):271-278. PubMed ID: 29081027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study.
    Zhao Y; Cai M; Jiang Z; Dong B; Yan Y; Wang Y; Zuo L
    Ren Fail; 2022 Dec; 44(1):428-433. PubMed ID: 35272568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasensitive Quantitation of Anti-Phospholipase A2 Receptor Antibody as A Diagnostic and Prognostic Indicator of Idiopathic Membranous Nephropathy.
    Zhang Q; Huang B; Liu X; Liu B; Zhang Y; Zhang Z; Hua J; Fan Y; Hu L; Meng M; Wu M; Wang L; Hu Z; Sun Z
    Sci Rep; 2017 Sep; 7(1):12049. PubMed ID: 28935926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN).
    Radice A; Trezzi B; Maggiore U; Pregnolato F; Stellato T; Napodano P; Rolla D; Pesce G; D'Amico M; Santoro D; Londrino F; Ravera F; Ortisi G; Sinico RA
    Autoimmun Rev; 2016 Feb; 15(2):146-54. PubMed ID: 26527329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Glomerular IgG Subclasses Switch in Idiopathic Membranous Nephropathy Classified by Glomerular Phospholipase A2 Receptor Antigen and Serum Antibody.
    Cui HY; Li C; Li H; Wen YB; Duan L; Li Y; Yan XW; Hu YT; Chen LM; Li XM
    Dis Markers; 2021; 2021():9965343. PubMed ID: 34497677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Phospholipase A2 Receptor (Anti-PLA2R) Antibody in Diagnosis and Treatment of Idiopathic Membranous Nephropathy: A Single-Center Observational Study in China.
    Guo N; Cao Y; Dai H; Yuan L; Shi L; Zhang Y
    Med Sci Monit; 2019 Dec; 25():9364-9368. PubMed ID: 31813930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic value of renal phospholipase A2 receptor and serum anti-phospholipase A2 receptor antibody in membranous nephropathy].
    Wu X; Wen S; Zhu X; Yuan S; Xu X; Yang D; Sun L; Liu H; Liu F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Apr; 42(4):395-399. PubMed ID: 28490696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-phospholipase A2 receptor (anti-PLA2R) antibodies and idiopathic membranous nephropathy: which role in diagnosis and prognosis of this disease?].
    Netti GS; Ranieri E
    G Ital Nefrol; 2014; 31(3):. PubMed ID: 25030016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definition of a new cut-off for the anti-phospholipase A2 receptor (PLA2R) autoantibody immunoassay in patients affected by idiopathic membranous nephropathy.
    Tampoia M; Migliucci F; Villani C; Abbracciavento L; Rossini M; Fumarulo R; Gesualdo L; Montinaro V
    J Nephrol; 2018 Dec; 31(6):899-905. PubMed ID: 30187382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy.
    Kumar V; Ramachandran R; Kumar A; Nada R; Suri D; Gupta A; Kohli HS; Gupta KL; Jha V
    Nephrology (Carlton); 2015 Aug; 20(8):572-5. PubMed ID: 26194981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnosis accuracy of PLA2R-AB in the diagnosis of idiopathic membranous nephropathy: a meta-analysis.
    Du Y; Li J; He F; Lv Y; Liu W; Wu P; Huang J; Wei S; Gao H
    PLoS One; 2014; 9(8):e104936. PubMed ID: 25136841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLA2R and membranous nephropathy: A 3 year prospective Australian study.
    Hill PA; McRae JL; Dwyer KM
    Nephrology (Carlton); 2016 May; 21(5):397-403. PubMed ID: 26369693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of anti-phospholipase A2 receptor antibody and C5a complement with disease activity and short-term outcome in idiopathic membranous nephropathy.
    Chi JN; Lai TS; Wu CF; Fu TY; Chou YH; Chiu YL; Lin WC; Chiang WC; Chen YM; Wu MS
    J Formos Med Assoc; 2019 May; 118(5):898-906. PubMed ID: 30639075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of PLA2R autoantibodies and glomerular staining for the differentiation of idiopathic and secondary membranous nephropathy: an updated meta-analysis.
    Dai H; Zhang H; He Y
    Sci Rep; 2015 Mar; 5():8803. PubMed ID: 25740009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.
    Hoxha E; Kneißler U; Stege G; Zahner G; Thiele I; Panzer U; Harendza S; Helmchen UM; Stahl RA
    Kidney Int; 2012 Oct; 82(7):797-804. PubMed ID: 22673885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The correlation between anti-phospholipase A2 receptor antibodies and hypercoagulability in patients with idiopathic membranous nephropathy.
    Liu Y; Tang Y; Le WB; Chen D; Liang D; Xu F; Liang S; Zhong Y; Zeng C
    Ren Fail; 2024 Dec; 46(2):2374448. PubMed ID: 38973428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Antibody and Glomerular Antigen of Antiphospholipase A2 Receptor in Chinese Patients with Idiopathic Membranous Nephropathy.
    Zhang QH; Wu M; Hu ZG; Liu XB; Huang B; Zhang Y; Liu B; Zhu YS; Wang L; Sun ZX
    Biomed Res Int; 2020; 2020():1693710. PubMed ID: 32461964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating anti-phospholipase A2 receptor antibodies as a diagnostic and prognostic marker in Greek patients with idiopathic membranous nephropathy - a retrospective cohort study.
    Provatopoulou S; Kalavrizioti D; Stangou M; Kouri MN; Kalliakmani P; Papasotiriou M; Papachristou E; Goumenos DS; Papagianni A
    Rom J Intern Med; 2019 Jun; 57(2):141-150. PubMed ID: 30864406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.